Xiamen Kingdomway Group Company (002626.SZ) has a MoatMap StockRank of 17/100 based on Quality (46/100), Value (27/100), and Momentum (29/100) factor scores. The current signal is STRONG SELL. Xiamen Kingdomway Group manufactures coenzyme Q10, vitamins, and nutritional ingredients. It operates in a highly competitive, commodity-like chemical synthesis market with limited pricing power, failing the Terry Smith quality compounder criteria.
Xiamen Kingdomway Group is a leading global manufacturer of nutritional ingredients, including Coenzyme Q10, Vitamin A, and Vitamin D3. The company is vertically integrated, owning both large-scale raw material production facilities and premium consumer supplement brands like Doctor's Best. It commands a significant share of the global nutrition and anti-aging ingredient markets.
| Price | $2.09 |
| Market Cap | $1.4B |
| P/E (TTM) | 32.02 |
| P/E (Forward) | 18.19 |
| Price/Book | 1.96 |
| Return on Equity | 5.9% |
| Return on Invested Capital | 6.8% |
| Debt/Equity | 52.88 |
| Gross Margin | 36.8% |
| Operating Margin | 13.8% |
| Revenue Growth | -1.7% |
| Dividend Yield | 2.7% |
| Free Cash Flow | $-396K |
Xiamen Kingdomway Group Company operates in the Packaged Foods industry, part of the Consumer Defensive sector (China).